CA2193178A1 - Inhibiteurs de la metalloprotease matricielle - Google Patents

Inhibiteurs de la metalloprotease matricielle

Info

Publication number
CA2193178A1
CA2193178A1 CA002193178A CA2193178A CA2193178A1 CA 2193178 A1 CA2193178 A1 CA 2193178A1 CA 002193178 A CA002193178 A CA 002193178A CA 2193178 A CA2193178 A CA 2193178A CA 2193178 A1 CA2193178 A1 CA 2193178A1
Authority
CA
Canada
Prior art keywords
cycloalkyl
lower alkyl
cycloalkylalkyl
hydrogen
heteroaralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002193178A
Other languages
English (en)
Other versions
CA2193178C (fr
Inventor
Steven Lee Bender
Chris Allen Broka
Jeffrey Allen Campbell
Arlindo Lucas Castelhano
Robert Than Hendricks
Keshab Sarma
Lawrence Emerson Fisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Agouron Pharmaceuticals LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2193178A1 publication Critical patent/CA2193178A1/fr
Application granted granted Critical
Publication of CA2193178C publication Critical patent/CA2193178C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2193178 1995-12-20 1996-12-17 Inhibiteurs de la metalloprotease matricielle Expired - Fee Related CA2193178C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US893995P 1995-12-20 1995-12-20
US60/008,939 1995-12-20
US2243996P 1996-08-07 1996-08-07
US60/022,439 1996-08-07

Publications (2)

Publication Number Publication Date
CA2193178A1 true CA2193178A1 (fr) 1997-06-21
CA2193178C CA2193178C (fr) 2001-11-06

Family

ID=26678819

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2193178 Expired - Fee Related CA2193178C (fr) 1995-12-20 1996-12-17 Inhibiteurs de la metalloprotease matricielle

Country Status (2)

Country Link
CA (1) CA2193178C (fr)
TW (1) TW580491B (fr)

Also Published As

Publication number Publication date
CA2193178C (fr) 2001-11-06
TW580491B (en) 2004-03-21

Similar Documents

Publication Publication Date Title
MY117574A (en) Matrix metalloprotease inhibitors
GB9803226D0 (en) Chemical compounds
BG106073A (en) Quinoline derivatives as inhibitors of mek enzymes
CA2155104A1 (fr) Derives de substitution heterocycliques d'un alkylamide, inhibiteurs d'acat
MXPA04006709A (es) Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
NZ505638A (en) Bicyclic pyrrole derivatives as MCP-1 inhibitors
NZ335157A (en) N-(aryl/heteroaryl) amino acid derivatives and methods for inhibiting beta-amyloid peptide release or its synthesis
HU914092D0 (en) Process for producing cyclic compounds containing amino or nitro group and acting as enzyme inhibitor
EP1008592A3 (fr) Dérivés d'amides cycliques utiles comme inhibiteurs de la cathepsin K
AU9426098A (en) Azetidinone derivatives for the treatment of hcmv infections
EP0760368A4 (fr) Nouveau derive de pyrimidine
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
AU2177997A (en) Anticachectic composition
CA2247946A1 (fr) Composition anticachexique
CA2376691A1 (fr) N-aralkyl amines cycliques antipsychotiques
WO1999023092A3 (fr) 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine
IL116646A0 (en) Antifungal fusacandins
ECSP961987A (es) Inhibidores de metaloproteasa de matriz (caso ran 4070/106)
ES2017032A6 (es) Procedimiento para la obtencion de 4,5-dihidro-3(2h)-piridazinonas.
IL107043A0 (en) Novel pharmaceutically active flavilium compounds
CA2036643A1 (fr) Esters contenant du soufre en tant que synergiseur d'antioxydant phenolique et amine
TW207997B (fr)
ATE258545T1 (de) Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
TW342411B (en) 3-(Dihydrobenzofuran-5-yl)benzofuran-2-ones as stabilisers

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131217